In B-cell chronic lymphoid leukemia (CLL) cell lines, the overexpression of PRMT5 is due to its enhanced translation, caused by an alteration of the expression of miR-19a, -25, -32, -92b, and -96, which targets PRMT5. The gene discussed is PRMT5; the disease is B-cell chronic lymphocytic leukemia.